Total Payments
$314.45
2023 Payments
$16.27
Companies
6
Transactions
12
Medicare Patients
3,041
Medicare Billing
$353,440
Payment Breakdown by Category
Food & Beverage$314.45 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $314.45 | 12 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $119.41 | 1 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $87.02 | 5 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $52.79 | 3 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $23.68 | 1 | $0 (2017) |
| Otsuka America Pharmaceutical, Inc. | $16.69 | 1 | $0 (2018) |
| PFIZER INC. | $14.86 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $16.27 | 1 | Janssen Pharmaceuticals, Inc ($16.27) |
| 2021 | $96.61 | 5 | Janssen Pharmaceuticals, Inc ($57.60) |
| 2019 | $132.56 | 2 | AstraZeneca Pharmaceuticals LP ($119.41) |
| 2018 | $16.69 | 1 | Otsuka America Pharmaceutical, Inc. ($16.69) |
| 2017 | $52.32 | 3 | Novartis Pharmaceuticals Corporation ($23.68) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/01/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/19/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/06/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/01/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/19/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $22.87 | General |
| Category: Cardiovascular | ||||||
| 01/21/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.14 | General |
| Category: Cardiovascular | ||||||
| 10/16/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/17/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $119.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/27/2018 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: NEPHROLOGY | ||||||
| 04/12/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/31/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.78 | General |
| Category: Cardiovascular | ||||||
| 02/24/2017 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 876 | 1,297 | $686,060 | $110,290 |
| 2022 | 12 | 976 | 1,498 | $488,952 | $115,142 |
| 2021 | 9 | 551 | 815 | $261,856 | $58,572 |
| 2020 | 10 | 638 | 930 | $357,509 | $69,435 |
Total Patients
3,041
Total Services
4,540
Medicare Billing
$353,440
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 137 | 272 | $133,136 | $24,792 | 18.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 190 | 381 | $125,658 | $23,118 | 18.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 134 | 139 | $137,888 | $19,309 | 14.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 175 | 189 | $108,805 | $16,821 | 15.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 69 | 72 | $46,986 | $7,399 | 15.7% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 29 | 40 | $25,400 | $3,266 | 12.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 52 | 52 | $15,437 | $3,265 | 21.2% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 23 | 31 | $27,869 | $3,209 | 11.5% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2023 | 27 | 30 | $21,750 | $3,058 | 14.1% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 13 | 25 | $23,400 | $2,977 | 12.7% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 12 | 41 | $7,656 | $1,632 | 21.3% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 15 | 25 | $12,075 | $1,444 | 12.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 258 | 555 | $185,714 | $47,074 | 25.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 267 | 274 | $97,714 | $23,664 | 24.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 226 | 378 | $84,940 | $22,018 | 25.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 41 | 42 | $34,943 | $6,756 | 19.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 27 | 27 | $14,198 | $2,871 | 20.2% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 49 | 50 | $12,198 | $2,839 | 23.3% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 13 | 38 | $24,130 | $2,685 | 11.1% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 21 | 21 | $9,932 | $2,164 | 21.8% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 40 | 67 | $9,130 | $2,159 | 23.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 11 | 21 | $4,095 | $1,183 | 28.9% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2022 | 11 | 12 | $8,700 | $968.16 | 11.1% |
| 99225 | Follow-up observation care per day, typically 25 minutes | Facility | 2022 | 12 | 13 | $3,257 | $757.94 | 23.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 135 | 243 | $91,087 | $20,167 | 22.1% |
About Dr. Babak Pirouz, MD
Dr. Babak Pirouz, MD is a Internal Medicine healthcare provider based in Meadowbrook, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/26/2007. The National Provider Identifier (NPI) number assigned to this provider is 1609072578.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Babak Pirouz, MD has received a total of $314.45 in payments from pharmaceutical and medical device companies, with $16.27 received in 2023. These payments were reported across 12 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($314.45).
As a Medicare-enrolled provider, Pirouz has provided services to 3,041 Medicare beneficiaries, totaling 4,540 services with total Medicare billing of $353,440. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine, Internal Medicine
- Location Meadowbrook, PA
- Active Since 06/26/2007
- Last Updated 11/10/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1609072578
Products in Payments
- FARXIGA (Drug) $119.41
- XARELTO (Drug) $87.02
- ELIQUIS (Drug) $67.65
- ENTRESTO (Drug) $23.68
- SAMSCA (Drug) $16.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Meadowbrook
David Litt, Md, MD
Internal Medicine — Payments: $3,821
Internal Medicine $3,821
John Butler, Md, MD
Internal Medicine — Payments: $2,871
Internal Medicine $2,871
Dominick Galluzzo, Md, MD
Internal Medicine — Payments: $2,072
Internal Medicine $2,072
Dr. Leonard Khrizman, M.d, M.D
Internal Medicine — Payments: $551.55
Internal Medicine $551.55
Joseph Viknevich, M.d, M.D
Internal Medicine — Payments: $453.22
Internal Medicine $453.22
Maureen Armstrong, Do, DO
Internal Medicine — Payments: $121.36
Internal Medicine $121.36